Additional Proxy Soliciting Materials (definitive) (defa14a)
March 29 2017 - 4:10PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
Filed by the Registrant
x
Filed by a Party other than
the Registrant
¨
Check the appropriate box:
¨
|
Preliminary Proxy Statement
|
¨
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
¨
|
Definitive Proxy Statement
|
x
|
Definitive Additional Materials
|
¨
|
Soliciting Material Pursuant to §240.14a-12
|
Protalix BioTherapeutics, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)
Payment of Filing Fee (Check
the appropriate box):
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set
|
|
|
forth the amount on which the filing fee is calculated and state how it was determined):
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
5)
|
Total fee paid:
|
¨
|
Fee paid previously with preliminary materials.
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing:
|
|
1)
|
Amount Previously Paid:
|
|
2)
|
Form, Schedule or Registration Statement No:
|
|
3)
|
Filing Party:
|
|
4)
|
Date Filed:
|
March 29, 2017
Dear Stockholder,
According to our latest records, we have not
yet received your proxy for the important Annual Meeting of stockholders of Protalix BioTherapeutics, Inc. to be held on April
12, 2017.
Your Board of Directors has unanimously recommended that shareholders return the enclosed proxy card voting FOR all
of the items on the agenda.
Your vote is important
, no matter how
many or how few shares you may own.
Please vote TODAY by telephone,
via
the Internet, or by signing, dating and returning
the enclosed proxy card in the envelope provided to ensure that your votes are validly received prior to the Annual Meeting.
Please be aware that your broker has set
April 10, 2017 at 11:59 PM EDT as the voting deadline.
Thank you for your support.
Sincerely,
Yossi Maimon
Vice President and Chief Financial Officer
REMEMBER:
You can vote your shares by telephone,
or
via
the Internet.
Please follow the easy instructions
on the enclosed card.
If you have any questions,
or need assistance in voting
your shares, please
call our proxy solicitor,
INNISFREE M&A
INCORPORATED
TOLL-FREE, at 1-888-750-5834.
|
Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
From Apr 2023 to Apr 2024